Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
The 10% tariffs on Chinese goods began Tuesday. China reacted with a 15% tariff on coal and liquefied natural gas and a 10% tariff on crude oil, agricultural machinery, large-displacement automobiles ...
ImpediMed has received $15m in funding for five years from SWK Holdings, which is set to enhance its ability to grow and ...